Nanobiotix (NBTX) Competitors $4.15 +0.24 (+6.14%) (As of 12:01 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NBTX vs. CRON, NUVB, TRDA, ANNX, STOK, CRMD, ORIC, TRML, EXAI, and ABUSShould you be buying Nanobiotix stock or one of its competitors? The main competitors of Nanobiotix include Cronos Group (CRON), Nuvation Bio (NUVB), Entrada Therapeutics (TRDA), Annexon (ANNX), Stoke Therapeutics (STOK), CorMedix (CRMD), ORIC Pharmaceuticals (ORIC), Tourmaline Bio (TRML), Exscientia (EXAI), and Arbutus Biopharma (ABUS). These companies are all part of the "pharmaceutical products" industry. Nanobiotix vs. Cronos Group Nuvation Bio Entrada Therapeutics Annexon Stoke Therapeutics CorMedix ORIC Pharmaceuticals Tourmaline Bio Exscientia Arbutus Biopharma Nanobiotix (NASDAQ:NBTX) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability. Do analysts rate NBTX or CRON? Nanobiotix currently has a consensus target price of $11.50, suggesting a potential upside of 177.11%. Cronos Group has a consensus target price of $3.00, suggesting a potential upside of 42.86%. Given Nanobiotix's stronger consensus rating and higher probable upside, equities analysts clearly believe Nanobiotix is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanobiotix 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Cronos Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do insiders and institutionals hold more shares of NBTX or CRON? 38.8% of Nanobiotix shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 3.5% of Nanobiotix shares are owned by insiders. Comparatively, 6.9% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer NBTX or CRON? Cronos Group received 453 more outperform votes than Nanobiotix when rated by MarketBeat users. However, 64.71% of users gave Nanobiotix an outperform vote while only 61.13% of users gave Cronos Group an outperform vote. CompanyUnderperformOutperformNanobiotixOutperform Votes1164.71% Underperform Votes635.29% Cronos GroupOutperform Votes46461.13% Underperform Votes29538.87% Does the media prefer NBTX or CRON? In the previous week, Cronos Group had 5 more articles in the media than Nanobiotix. MarketBeat recorded 9 mentions for Cronos Group and 4 mentions for Nanobiotix. Nanobiotix's average media sentiment score of 1.02 beat Cronos Group's score of 0.21 indicating that Nanobiotix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nanobiotix 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is NBTX or CRON more profitable? Nanobiotix has a net margin of 0.00% compared to Cronos Group's net margin of -42.65%. Nanobiotix's return on equity of 0.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets NanobiotixN/A N/A N/A Cronos Group -42.65%-2.60%-2.51% Which has better earnings and valuation, NBTX or CRON? Nanobiotix has higher earnings, but lower revenue than Cronos Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanobiotix$39.18M4.99-$42.97MN/AN/ACronos Group$101.78M7.89-$73.96M-$0.13-16.15 Which has more risk & volatility, NBTX or CRON? Nanobiotix has a beta of 0.33, suggesting that its share price is 67% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. SummaryNanobiotix beats Cronos Group on 10 of the 16 factors compared between the two stocks. Ad DTIWhy buying gold might be a mistakeSomething strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level.If you're interested, check out the recording here while the link's still up. Get Nanobiotix News Delivered to You Automatically Sign up to receive the latest news and ratings for NBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NBTX vs. The Competition Export to ExcelMetricNanobiotixPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$195.59M$7.11B$5.33B$8.91BDividend YieldN/A8.03%4.98%4.03%P/E RatioN/A11.25135.4417.46Price / Sales4.99393.051,266.8895.47Price / CashN/A49.2238.8936.42Price / Book-103.759.126.315.92Net Income-$42.97M$153.75M$118.33M$224.86M7 Day Performance-3.49%-1.20%-1.43%-0.38%1 Month Performance-14.61%8.48%3.12%4.21%1 Year Performance-28.69%39.61%36.57%27.31% Nanobiotix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NBTXNanobiotix2.3839 of 5 stars$4.15+6.1%$11.50+177.1%-32.4%$195.59M$39.18M0.00100News CoverageGap UpCRONCronos Group2.0507 of 5 stars$1.97-1.5%N/A+8.0%$753.13M$87.24M-13.13356Short Interest ↓Analyst RevisionNews CoverageNUVBNuvation Bio2.3697 of 5 stars$3.01+4.2%N/A+129.6%$748.98M$2.16M-1.3860Analyst RevisionGap DownHigh Trading VolumeTRDAEntrada Therapeutics1.7457 of 5 stars$19.89+0.4%N/A+21.8%$744.28M$215.23M12.51110Insider SellingPositive NewsANNXAnnexon2.9305 of 5 stars$6.97-3.6%N/A+189.8%$736.38MN/A-5.6760Short Interest ↓News CoverageGap UpSTOKStoke Therapeutics3.947 of 5 stars$13.81-0.5%N/A+225.5%$731.52M$8.78M-6.58100Positive NewsCRMDCorMedix2.6943 of 5 stars$12.04+3.8%N/A+265.0%$730.55M$12.26M-14.8630Short Interest ↓ORICORIC Pharmaceuticals4.2858 of 5 stars$10.30+0.4%N/A+67.5%$726.58MN/A-5.8980Earnings ReportAnalyst ForecastNews CoverageTRMLTourmaline Bio2.7706 of 5 stars$28.32-1.5%N/A+61.1%$726.13MN/A-10.0444Earnings ReportAnalyst ForecastAnalyst RevisionEXAIExscientia2.7908 of 5 stars$5.96+9.6%N/A+3.7%$720.49M$21.02M-4.58280News CoverageHigh Trading VolumeABUSArbutus Biopharma2.8688 of 5 stars$3.73-0.5%N/A+103.9%$706.80M$18.14M-8.6773Short Interest ↓Analyst Revision Related Companies and Tools Related Companies Cronos Group Competitors Nuvation Bio Competitors Entrada Therapeutics Competitors Annexon Competitors Stoke Therapeutics Competitors CorMedix Competitors ORIC Pharmaceuticals Competitors Tourmaline Bio Competitors Exscientia Competitors Arbutus Biopharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NBTX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
